Investor Event

ShareSoc & Walbrook PR Healthcare Companies Seminar, (IN-PERSON EVENT) London – 19 Oct 2023, 5pm

Companies presenting:
Tristel Plc (TSTL)
Inspiration Healthcare Group (IHC)
Creo Medical Group (CREO)
Abingdon Health (ABDX)
GENincode (GENI)

Featuring: Tristel Plc (TSTL), Inspiration Healthcare Group (IHC), Creo Medical Group (CREO), Abingdon Health (ABDX) and GENincode (GENI)

Tristel Plc (TSTL): Tristel plc is a UK-based manufacturer of infection prevention products. The Company’s core business is the sale to hospitals of its Chlorine Dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. Tristel’s powerful and fast acting disinfectant uses a proprietary formulation of Chlorine Dioxide and is used in nearly every NHS hospital to decontaminate medical devices or as a surface disinfectant, as well as across 30 plus countries worldwide.
Speakers: Paul Swinney (CEO) and Liz Dixon (CFO)

Inspiration Healthcare Group (IHC): Inspiration Healthcare is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
The Company has key own-brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.
Speakers: Neil Campbell (CEO) and Alan Olby (CFO)

Creo Medical Group (CREO):  Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue. Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions. CROMA currently delivers bipolar radiofrequency (“RF”) energy for precise localised cutting and focused high-frequency microwave (“MW”) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with the Group’s range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions. The Directors believe the Company’s technology can impact the landscape of surgery and endoscopy by providing a safer, less invasive and more cost-efficient option for procedures.
Speaker: Craig Gulliford (CEO)

Abingdon Health (ABDX): Abingdon Health is a leading lateral flow contract development and manufacturing organisation (“CDMO”) offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing.
The Company’s CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in, allowing for rapid decision making, targeted intervention and supporting better outcomes.
Speakers: Chris Yates (CEO) and Melanie Ross (CFO)

GENincode (GENI): GENinCode plc is a UK-based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode’s CE marked in vitro diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict the onset of cardiovascular disease.
Speakers: Matthew Walls (CEO) and Paul Foulger (CFO)

The seminar will consist of a 15-minute presentation, followed by a 15-minute Q&A session, for each company. You will be able to engage directly with company directors and network with fellow investors.

There are limited spaces available, which will be processed on a first-come, first-served basis.

Event registration opens at 4.30 pm and presentations commence at 5.00 pm.
Networking will be from 8:00pm to 9:00pm.

Registration
If you are already a member of ShareSoc, you must log in prior to registering, then just click “SUBMIT” below. If you are not a ShareSoc member, you will automatically be registered as a free, associate member by registering for this event.

Click here for help on logging in.

Add to calendar
Event Details:
  • Event: ShareSoc & Walbrook PR Healthcare Companies Seminar, (IN-PERSON EVENT) London - 19 October 2023, 5pm
  • Date: 19/10/2023
  • Time: Presentations Start at 5pm
  • Location: ISH Venues
  • Address: 1 Park Crescent
  • City: London
  • Postcode: W1B 1SH
  • Country: UK

USE THIS FORM TO REGISTER FOR THE EVENT

A telephone number is only requested in case of query. It can be omitted if preferred. A postal address is required but will only be used in exceptional circumstances. Communication will normally be via email.

IMPORTANT: You should receive confirmation via email of your registration within 48 hours of submitting it using the above form. If for any reason, that does not arrive, please let us know immediately by telephoning 0333-200-1595. Running order and companies presenting are subject to change so please check this web page nearer the date if you have an interest in a particular company.

Add to calendar
Event Details:
  • Event ShareSoc & Walbrook PR Healthcare Companies Seminar, (IN-PERSON EVENT) London - 19 October 2023, 5pm
  • Date 19/10/2023
  • Time Presentations Start at 5pm
  • Location ISH Venues
  • Address 1 Park Crescent
  • City London
  • Postcode W1B 1SH
  • Country UK
  • Description Companies presenting:
    Tristel Plc (TSTL)
    Inspiration Healthcare Group (IHC)
    Creo Medical Group (CREO)
    Abingdon Health (ABDX)
    GENincode (GENI)